Uma Borate

Assistant Professor

  • 609 Citations
  • 12 h-Index
20092019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Uma Borate is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Systemic Mastocytosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Cytogenetics Medicine & Life Sciences
Guidelines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 609 Citations
  • 12 h-Index
  • 17 Article
  • 5 Review article
  • 3 Letter
  • 2 Chapter
Open Access
Myelodysplastic Syndromes
Homologous Transplantation
Acute Myeloid Leukemia
Hematopoietic Stem Cell Transplantation
Transplantation
2 Citations (Scopus)

Novel Approaches for Systemic Mastocytosis

Fletcher, L. & Borate, U., Mar 1 2019, In : Current Opinion in Hematology. 26, 2, p. 112-118 7 p.

Research output: Contribution to journalArticle

Systemic Mastocytosis
4'-N-benzoylstaurosporine
Clinical Trials
Mutation
Proto-Oncogenes

Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years

Borate, U., Norris, B. A., Statler, A., Fu, R., Bucy, T. & Sekeres, M. A., Sep 24 2019, In : Blood Advances. 3, 18, p. 2738-2747 10 p.

Research output: Contribution to journalArticle

Open Access
Myelodysplastic Syndromes
Clinical Trials
Therapeutics
National Cancer Institute (U.S.)
Radiotherapy

Applicability of the AML knowledge bank approach

Borate, U., Aug 23 2018, In : Blood. 132, 8, p. 775-776 2 p.

Research output: Contribution to journalReview article

Chemotherapy
Tertiary Care Centers
Acute Myeloid Leukemia
Blood
Databases

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia

Kurtz, S. E., Eide, C. A., Kaempf, A., Mori, M. T., Tognon, C. E., Borate, U., Druker, B. & Tyner, J., Sep 1 2018, In : Leukemia. 32, 9, p. 2025-2028 4 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Phosphotransferases
Therapeutics